Hilar cholangiocarcinoma is a fatal malignancy leading to high mortality rate despite recent therapeutic advances, and the photodynamic therapy has been noted as an emerging palliative strategy for the hilar cholangiocarcinoma. Photodynamic therapy is the treatment selectively destructing cancer tissue through the laser beam irradiation with particular wavelengths. Photosensitizer administered before the treatment is accumulated in malignant tissue, and activated in the limits of those wavelengths. The procedure is performed under percutaneous transhepatic biliary drainage or endoscopic retrograde cholangiopancreatography, and more appropriate for the periductal infiltrating type rather than mass-forming type of cholangiocarcinoma due to th...
Hilar cholangiocarcinoma (CC) is non-resectable in the majority of patients often due to intrahepati...
The therapeutic and diagnostic modalities of light are well known, and derivative photodynamic react...
BACKGROUND & AIMS: Successful treatment in nonresectable Bismuth type III and IV cholangiocarcin...
AbstractPhotodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photo...
Cholangiocarcinoma is a challenge to manage; mortality rate is nearly as high as the incidence. Unle...
The prognosis of bile duct cancer (BDC) is limited due to tumor spread along the biliary tree leadin...
AbstractBackgroundThe majority of patients with hilar cholangiocarcinoma have irresectable disease a...
Background: The majority of patients with hilar cholangiocarcinoma have irresectable disease and req...
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time ...
Cholangiocarcinoma is, in most cases, rapidly fatal. Curative resection can only be offered to appro...
The prognosis of nonresectable cholangiocarcinoma is dismal, and in Bismuth type III and IV tumors r...
Biliary tract cancers are rare malignancies usually characterized by slow growth and a low propensit...
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors rel...
PURPOSE OF REVIEW: Photodynamic therapy (PDT) with hematoporphyrins has emerged as promising treatme...
Background/Aims: Patients with cholangiocarcinoma usu-ally present at an advanced stage, and more th...
Hilar cholangiocarcinoma (CC) is non-resectable in the majority of patients often due to intrahepati...
The therapeutic and diagnostic modalities of light are well known, and derivative photodynamic react...
BACKGROUND & AIMS: Successful treatment in nonresectable Bismuth type III and IV cholangiocarcin...
AbstractPhotodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photo...
Cholangiocarcinoma is a challenge to manage; mortality rate is nearly as high as the incidence. Unle...
The prognosis of bile duct cancer (BDC) is limited due to tumor spread along the biliary tree leadin...
AbstractBackgroundThe majority of patients with hilar cholangiocarcinoma have irresectable disease a...
Background: The majority of patients with hilar cholangiocarcinoma have irresectable disease and req...
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time ...
Cholangiocarcinoma is, in most cases, rapidly fatal. Curative resection can only be offered to appro...
The prognosis of nonresectable cholangiocarcinoma is dismal, and in Bismuth type III and IV tumors r...
Biliary tract cancers are rare malignancies usually characterized by slow growth and a low propensit...
Prognosis of nonresectable cholangiocarcinoma is not good, and in Bismuth type III and IV tumors rel...
PURPOSE OF REVIEW: Photodynamic therapy (PDT) with hematoporphyrins has emerged as promising treatme...
Background/Aims: Patients with cholangiocarcinoma usu-ally present at an advanced stage, and more th...
Hilar cholangiocarcinoma (CC) is non-resectable in the majority of patients often due to intrahepati...
The therapeutic and diagnostic modalities of light are well known, and derivative photodynamic react...
BACKGROUND & AIMS: Successful treatment in nonresectable Bismuth type III and IV cholangiocarcin...